Is Incyte Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Incyte Corp (INCY) is currently classified as HALAL as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Incyte Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Incyte Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Incyte Corp?

Muslim investors may consider investing in Incyte Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Incyte Corp classified as HALAL?

Musaffa determines the Shariah status of Incyte Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Incyte Corp updated?

The Shariah compliance status of Incyte Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Incyte Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Incyte Corp?

You can check the latest Shariah compliance status of Incyte Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

INCY Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: May 04, 2026

Report Source: 2026 1st Quarter Report

Incyte Corp. Stock Analysis INCY

United States Health Care Large Cap Report: Q1, 2026

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. The company is headquartered in Wilmington, Delaware and currently employs 2,844 full-time employees. The firm operates in two therapeutic areas. One therapeutic area is Hematology/Oncology, which is comprised of Myeloproliferative Neoplasms and Graft-Versus-Host Disease, as well as solid tumors and hematologic malignancies. Its other therapeutic area is Inflammation and Autoimmunity, which includes its Dermatology commercial franchise. Its hematology and oncology franchise are comprised of six products, which are JAKAFI (ruxolitinib), MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab), PEMAZYRE (pemigatinib), ICLUSIG (ponatinib), NIKTIMVO (axatilimab-csfr), and ZYNYZ (retifanlimab-dlwr), as well as numerous clinical development programs. The firm's pipeline also includes two first-in-class small molecule antagonist of Mas-related G protein-coupled receptor (MRGPRX2) and INCB000547, an oral MRGPRX4 antagonist.

Key Statistics of Incyte Corp (INCY)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$94.31$97.70

Today's Open

$97.44

Volume

1.65M

P/E Ratio (TTM)

15.05

52 Week Range

$57.77$112.29

Market Cap

19.47B

Avg. Volume

1.45M

Dividend Yield

Financial Metrics & Statements of Incyte Corp (INCY)

Community-Curated Collections with Incyte Corp (INCY) ( With INCY )

View All

Community-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.

Long Term Investment - US Stocks

By Saheem Mohamed

7 Followers

+49 more

My Watchlist

4 Followers

+59 more

Dodge & Cox Z

By Suhail Patel

0 Followers

+98 more

FAQ's for Incyte Corp (INCY)

According to Musaffa’s Shariah screening methodology, Incyte Corp (INCY) is currently classified as HALAL as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.